John Jarboe, PhD
Radiation Oncology · Montgomery, ALNPI 1447662804
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,758 of the $2,656 with a category attached, or 66.2%. 18 manufacturers reported payments, led by Icotec Medical Inc. at 35.4% of the total. Reporting peaked in 2022 at $1,224 and has fallen 93.9% since, to $75 in 2025.
Across 53 payments — averaging $50.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icotec Medical Inc.$940
- GT Medical Technologies, Inc$360
- Novocure Inc.$224
- Siemens Medical Solutions USA, Inc.$196
- Novartis$157
- Myovant Sciences Inc.$127
- plus $652 from 12 others
What the payments were for
- Travel & lodging$89834%
- Food & beverage$1,75866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icotec Medical Inc. | 3 | $940 |
| GT Medical Technologies, Inc | 3 | $360 |
| Novocure Inc. | 5 | $224 |
| Siemens Medical Solutions USA, Inc. | 5 | $196 |
| Novartis | 8 | $157 |
| Myovant Sciences Inc. | 6 | $127 |
| Sumitomo Pharma America, Inc. | 6 | $106 |
| MIM Software Inc. | 1 | $99 |
| Myriad Genetic Laboratories, Inc. | 3 | $95 |
| Varian Medical Systems, Inc. | 1 | $72 |
| AstraZeneca | 3 | $63 |
| Reflexion Medical, Inc. | 1 | $55 |
| Bayer | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $31 |
| Elekta, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Blue Earth Diagnostics | 1 | $21 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,656 in reported general payments places this provider in the 70th percentile of 87 radiation oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 59 | $2,228 |
| Pentoxifylline | 52 | $2,055 |
| Dexamethasone | 36 | $983 |
| Oxycodone Hcl | 13 | $636 |
| Memantine Hcl | 17 | $570 |
| Bicalutamide | 17 | $406 |
| Lidocaine Hcl ViscousLidocaine Hcl | 19 | $300 |
| Gabapentin | 13 | $207 |
| Methylprednisolone | 19 | $202 |
| Tamsulosin Hcl | 16 | $153 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Montgomery
- Alexander WhitleyMontgomery$441K
- Robert FranklinMontgomery$3K
- Michael IngramMontgomery$2K
- Thomas BeatrousMontgomery$2K
- Mayank PatelMontgomery$970
- Drexell BoggsBirmingham$35K
- Christopher JahrausAlabaster$28K
- Christopher WilleyBirmingham$13K
- Adam KoleBirmingham$11K
- William HixsonFairhope$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.